Switch to:

Castle Biosciences Debt-to-EBITDA

: -12.25 As of Jun. 2020
View and export this data going back to 2019. Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

Castle Biosciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $10.00 Mil. Castle Biosciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $14.74 Mil. Castle Biosciences's annualized EBITDA for the quarter that ended in Jun. 2020 was $-2.02 Mil. Castle Biosciences's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2020 was -12.25.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

NAS:CSTL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -6.51   Med: -1.79   Max: 2.44
Current: 2.26

-6.51
2.44

During the past 3 years, the highest Debt-to-EBITDA Ratio of Castle Biosciences was 2.44. The lowest was -6.51. And the median was -1.79.

NAS:CSTL's Debt-to-EBITDA is ranked lower than
55% of the 113 Companies
in the Medical Diagnostics & Research industry.

( Industry Median: 1.73 vs. NAS:CSTL: 2.26 )

Castle Biosciences Debt-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Castle Biosciences Annual Data
Dec17 Dec18 Dec19
Debt-to-EBITDA -1.79 -6.51 2.44

Castle Biosciences Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Debt-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.25 0.89 2.10 4.45 -12.25

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Castle Biosciences Debt-to-EBITDA Distribution

* The bar in red indicates where Castle Biosciences's Debt-to-EBITDA falls into.



Castle Biosciences Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Castle Biosciences's Debt-to-EBITDA for the fiscal year that ended in Dec. 2019 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.833 + 19.289) / 10.278
=2.44

Castle Biosciences's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2020 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(10 + 14.741) / -2.02
=-12.25

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2020) EBITDA data.


Castle Biosciences  (NAS:CSTL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Castle Biosciences Debt-to-EBITDA Related Terms


Castle Biosciences Debt-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)